CAH vs NUS: stock comparison and AI forecast
Cardinal Health Inc (CAH) and Nu Skin Enterprises, Inc. (NUS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CAH Cardinal Health Inc
- Price
- $271.72 +46.7% · 6M
- Market Cap
- $63.20B
- P/E Ratio
- 28.3x
- Size
- large-cap
- AI Forecast
NUS Nu Skin Enterprises, Inc.
- Market Cap
- $200M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- CAH is 316.7 times larger than NUS by market capitalization ($63.20B against $200M).
- CAH turns 0.7% of its revenue into net income, against -17.9% for NUS.
- NUS yields 5.82% in dividends; CAH pays none.
- Both companies share the SEC industry classification Wholesale-Drugs, Proprietaries & Druggists' Sundries.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CAH | NUS |
|---|---|---|
| Market Cap | $63.20B | $200M |
| P/E Ratio | 28.27x | – |
| P/B Ratio | – | 0.36x |
| Dividend Yield | – | 5.82% |
| EPS | $9.61 | $-4.89 |
| Book Value/Share | – | $11.25 |
| Revenue/Share | – | $27.16 |
| FCF/Share | – | $-0.54 |
Profitability & Margins
| Metric | CAH | NUS |
|---|---|---|
| ROE | – | -43.1% |
| ROA | – | -21.7% |
| ROIC | – | -3.2% |
| Gross Margin | 2.8% | 67.8% |
| Operating Margin | 0.8% | -2.0% |
| Net Margin | 0.7% | -17.9% |
| EBT Margin | 0.7% | -3.1% |
| Tax Rate | 21.0% | -476.4% |
Financial Health
| Metric | CAH | NUS |
|---|---|---|
| Current Ratio | 0.88x | 2.04x |
| Quick Ratio | 0.49x | 1.22x |
| D/E Ratio | – | 0.99x |
| Financial Leverage | – | 1.99x |
| Interest Coverage | 10.3x | 1.4x |
| Working Capital | -$5.34B | $244M |
Cash Flow
| Metric | CAH | NUS |
|---|---|---|
| Operating Cash Flow | $6.57B | $15M |
| Free Cash Flow | – | -$26M |
| Capital Spending | – | -$41M |
| OCF Growth YoY | 174.2% | -83.0% |
| FCF Growth YoY | – | -149.2% |
| FCF/Sales | – | -2.0% |
| CapEx/Sales | – | 3.1% |
Operational Efficiency
| Metric | CAH | NUS |
|---|---|---|
| Asset Turnover | – | 1.22x |
| Receivables Turnover | – | 25.7x |
| Inventory Turnover | 16.8x | 2.2x |
| Fixed Assets Turnover | – | 3.5x |
| Days Sales Outstanding | – | 14 days |
| Days Inventory | 22 days | 165 days |
| Payables Period | 48 days | 23 days |
| Cash Conversion Cycle | – | 156 days |
Income Statement
| Metric | CAH | NUS |
|---|---|---|
| Total Revenue | – | $1.32B |
| Operating Income | $3.37B | -$27M |
| Net Income | $2.86B | -$236M |
| SG&A Expense | $7.73B | $843M |
| Cost of Goods Sold | $309.39B | $425M |
Dividend & Shareholder Information
| Metric | CAH | NUS |
|---|---|---|
| Dividends Per Share | – | $0.24 |
| Shares Outstanding | 233M | 49M |
| Net Income Growth | 79.2% | -316.4% |
| EPS Growth | 49.0% | -325.4% |
CAH vs NUS: stock comparison and AI forecast
Which is bigger, CAH or NUS?
CAH is 316.7 times larger than NUS by market capitalization ($63.20B against $200M).
Which one does Intratio's AI model rank higher, CAH or NUS?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.